Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.7M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
16.3M
-
Shares change
-
+2.37M
-
Total reported value, excl. options
-
$426M
-
Value change
-
+$75.9M
-
Put/Call ratio
-
0.66
-
Number of buys
-
63
-
Number of sells
-
-21
-
Price
-
$26.14
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q2 2024
102 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q2 2024.
GeneDx Holdings Corp. - Common Stock (WGS) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.3M shares
of 28.7M outstanding shares and own 56.67% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3.53M shares), Corvex Management LP (2.47M shares), ORACLE INVESTMENT MANAGEMENT INC (1.11M shares), GOLDMAN SACHS GROUP INC (1.05M shares), BlackRock Inc. (925K shares), Blackstone Inc. (835K shares), VANGUARD GROUP INC (788K shares), GAGNON SECURITIES LLC (573K shares), Driehaus Capital Management LLC (434K shares), and DEUTSCHE BANK AG\ (391K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.